Price Stability Beyond the Fed: A Symposium
Introducing a symposium on the hottest topic in macroeconomics.
Introducing a symposium on the hottest topic in macroeconomics.
Industrial agriculture is a major contributor to climate change, as well as a source of exploitation across the globe. Any just transition from fossil fuels must radically rethink current systems of food production and work towards reaching food sovereignty.
In theory, REDD+ is designed to be a win-win: it brings capital to economically struggling communities while ensuring that forests worldwide are protected for the good of the global community. Yet as theory of the Stranger King makes apparent, some colonialist approaches are softer and gentler than others — colonizing as invitees, rather than by force.
A just transition for probation officers will never appeal to everyone. Nevertheless, it provides a potentially powerful framework for people who have experienced the dehumanizing mental and physical toll of working in the carceral state.
During the past decade the concept of a “just transition” has expanded far beyond its roots in the labor movement’s concern for protecting displaced fossil fuel workers. Should we welcome this expansion of the concept? Or will this generic use of ‘just transition’ undermine its usefulness as a framing device to guide policy and discourse?
Just Transition calls us to center questions of justice and distribution in the fight for an ecologically sustainable future. This call resonates deeply with the core concerns of LPE.
Muscles and arteries. Hammers and parasites. Addictions and complexes. Destin Jenkins concludes our Bonds of Inequality symposium by reflecting on the political implications of the metaphors we use to describe municipal debt.
Voters respond differently to policy options depending on how they are presented. Determining what constitutes ethical presentation demands an an exercise in prudence.
Americans pay excessively high prices for prescription drugs. To make medicines more affordable, the Biden Administration must confront the pharmaceutical industry’s monopoly power.
Municipal financing schemes have often distributed the benefits of spending along race and class lines, yet federal programs have a similarly mixed track record. How, then, can we safeguard public investment to secure just outcomes? The answer may reside in the details of agency and program design.
President Biden’s recent Executive Order on Promoting Competition brought much-needed attention to labor market concentration, employer collusion, and abusive employment contracts. Nevertheless, more action is needed to address systemic sources of employer power.
By failing to articulate a vision of fair competition, the White House has delegated the task of moral exposition to its cabinet secretaries and agency leaders. This move may not prove fatal to the aspirations of antimonopolists, as some agencies are well positioned to do the work.
Can public things meaningfully protect us from capitalism’s bottom line? If not, is our hope in them as a lever of progressive politics misplaced?
Neither Congress nor the Court have called for a one-size-fits-all approach to regulatory analysis, yet CBA continues to loom large in environmental policymaking. Agencies should reach for other tools that better capture the advantages and disadvantages of regulatory alternatives.
Economists who insist that the “value of a statistical life” can be determined solely by looking at the preferences of individual economic agents in a market overstate their case and miss crucial alternatives. The pandemic has shown that democratic determinations of value for non-market goods (like human life) deserve greater consideration.